What's new

Human medicines European public assessment report (EPAR): Adempas, riociguat, Date of authorisation: 27/03/2014, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Adempas, riociguat, Date of authorisation: 27/03/2014, Revision: 15, Status: Authorised

May 19, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Adempas, riociguat, Date of authorisation: 27/03/2014, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Adempas, riociguat, Date of authorisation: 27/03/2014, Revision: 15, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Noxafil, posaconazole,...

Next Article

Human medicines European public assessment report (EPAR): Briviact (in Italy: Nu...

Related Posts

Human medicines European public assessment report (EPAR): Atazanavir Viatris (previously Atazanavir Mylan), atazanavir, Date of authorisation: 22/08/2016, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

May 14, 2025  0

PSUSA/00002643/202408

PSUSA/00002643/202408

May 12, 2025  0

Human medicines European public assessment report (EPAR): Flucelvax, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 15/11/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0